Silexion Therapeutics OverviewSilexion Therapeutics Net Income
Profitability analysis for SLXN.
Quarterly Net Income
$2.73M
↑ 57.52% YoY
As of Mar 2026
Annual Net Income (TTM)
-$920000.00
↑ 93.1% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...